Skip to main content
logo
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.810
-0.030 (-1.63%)
Sep 17, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Therapeutics
16.18M
Log In
Log In
Log In
Log In
Upgrade
Therapeutics Growth
-42.66%
Log In
Log In
Log In
Log In
Upgrade
Contract Research
2.54M
Log In
Log In
Log In
Log In
Upgrade
Contract Research Growth
-16.28%
Log In
Log In
Log In
Log In
Upgrade
Corporate and Other
-
Log In
Log In
Log In
Log In
Upgrade
Corporate and Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
18.72M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-40.09%
Log In
Log In
Log In
Log In
Upgrade